National Access Clinic Corp. appointed Christopher Kane as COO.
Kane was most recently the senior vice president of operations and strategy at Drug Trading Ltd., a division of Katz Group Canada Ltd.
National Access Clinic names COO
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
National Access Clinic Corp. appointed Christopher Kane as COO.
Kane was most recently the senior vice president of operations and strategy at Drug Trading Ltd., a division of Katz Group Canada Ltd.